Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03096795” into
the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D9180C00001” into the search box, and click “Find a Study”.
Full Study Title: A Phase 1, Randomised, Blinded, Placebo-controlled Study
to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of
MEDI3506 Administered as Single Ascending Doses in Healthy Adult Subjects with
a History of Mild Atopy, as Multiple Ascending Doses in Adult Subjects with Chronic
Obstructive Pulmonary Disease and as a Single Dose in Healthy Japanese
Subjects
AstraZeneca Protocol Number: D9180C00001
National Clinical Trials Number: NCT03096795
MedImmune, a member of the AstraZeneca Group, sponsored this study and has
its headquarters at 1 Medimmune Way, Gaithersburg, MD 20878, United States of
America.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
12
Version 1.0 2021_02_02